financetom
Business
financetom
/
Business
/
Goodyear, other tire makers slam 'far fetched' price-fixing lawsuits
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Goodyear, other tire makers slam 'far fetched' price-fixing lawsuits
Sep 29, 2024 9:01 AM

Sept 23 (Reuters) - Goodyear, Bridgestone ( BRDCF ) and four other

tire manufacturers have asked a U.S. judge to dismiss a trio of

class action lawsuits accusing them of conspiring to overcharge

consumers and businesses in the multibillion-dollar market for

replacement tires.

The companies, also including Continental, Michelin, Nokian and

Pirelli, said in an Ohio court filing on Friday that the

lawsuits failed to provide any evidence that they agreed to fix

tire prices for passenger cars, trucks and other vehicles.

The antitrust cases from consumers, automobile dealerships

and other purchasers were assigned in June to the federal court

in Akron, Ohio.

The plaintiffs' claims were first lodged in February on the

heels of a European Commission antitrust probe of some tire

makers in Europe. The commission is the antitrust enforcer in

the 27-country European Union.

Lawyers for the plaintiffs and spokespeople for Continental,

Michelin, Nokian, Goodyear, Pirelli and Bridgestone ( BRDCF ) either had

no immediate comment or did not immediately respond to requests

for one.

The lawsuits estimated sales last year for replacement tires

reached $57 billion in the United States.

The plaintiffs contend the alleged conspiracy drove up the

average price of replacement tires in the United States by 21.4%

between 2021 and 2023. The lawsuits seek class-action status for

buyers from early 2020 to the present.

The tire makers in their joint court filing called the

claims "far-fetched" and said the plaintiffs had attempted to

"create a conspiracy out of thin air" with no evidence

substantiating the lawsuits. They said their pricing decisions

reflected "rational and competitive behavior in a concentrated

market."

The companies said the existence of the European Commission

probe was "insufficient, as a matter of law, to infer an

unlawful agreement under U.S. federal and state law."

Chief Judge Sara Lioi in the Northern District of Ohio was

assigned in June to hear the cases.

The case is In Re: Passenger Vehicle Replacement Tires

Antitrust Litigation, U.S. District Court, Northern District of

Ohio, No. 5:24-md-03107-SL.

Read more:

EU antitrust regulators raid consultancy in tyre cartel

investigation

Top tire makers are sued in US over alleged price fixing

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
May 31, 2025
* Trodelvy/Keytruda patients had 11.2 months progression-free survival vs 7.8 months for chemotherapy/Keytruda * ASCO says Trodelvy/Keytruda likely to become standard of care * Patients still being followed to see if combination extends survival By Deena Beasley May 31 (Reuters) - Gilead Sciences' ( GILD ) Trodelvy in combination with Merck's ( MRK ) blockbuster immunotherapy Keytruda lowered the risk...
Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression
Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression
May 31, 2025
May 31 (Reuters) - An experimental treatment by Pfizer ( PFE ) and Arvinas ( ARVN ) delayed progression of breast cancer by more than three months compared to AstraZeneca's ( AZN ) Faslodex in patients with a specific gene mutation, according to trial results announced on Saturday. The findings were presented in Chicago at the annual meeting of the...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
May 31, 2025
(Reuters) -Gilead Sciences' ( GILD ) Trodelvy in combination with Merck's ( MRK ) blockbuster immunotherapy Keytruda lowered the risk of an aggressive type of breast cancer worsening by 35% when used as an initial treatment, according to results of a large trial presented on Saturday. The data is likely to change how patients are treated following a diagnosis for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved